Kraig Biocraft Laboratories, Inc.
KBLB
$0.09
$0.0055.88%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.40M | -3.87M | -3.99M | -2.97M | -3.03M |
| Total Depreciation and Amortization | 92.50K | 100.50K | 48.50K | 47.90K | 47.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 736.20K | 1.32M | 1.51M | 755.40K | 864.10K |
| Change in Net Operating Assets | 731.10K | 794.70K | 848.60K | 828.80K | 873.20K |
| Cash from Operations | -1.84M | -1.65M | -1.58M | -1.34M | -1.24M |
| Capital Expenditure | -4.20K | 0.00 | -6.40K | -6.40K | -6.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 1.73M | 0.00 | 0.00 |
| Cash from Investing | -4.20K | 0.00 | 1.72M | -6.40K | -6.40K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -35.20K | -50.20K | -60.00K | -60.00K | -60.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -35.20K | -50.20K | -60.00K | -60.00K | -60.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.88M | -1.70M | 84.70K | -1.40M | -1.31M |